Publications by authors named "Robert Royer"

Claim this Profile
A
Activation of anti-oxidant Nrf2 signaling by enone analogues of curcumin.
Lorraine M Deck, Lucy A Hunsaker, Thomas A Vander Jagt, Lisa J Whalen, Robert E Royer

Eur J Med Chem· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high frequency of PALB2 mutations in Jamaican patients with breast cancer.
Jordan Lerner-Ellis, Talia Donenberg, Humayun Ahmed, Sophia George, Gilian Wharfe, Robert Royer

Breast Cancer Res Treat· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of anti-oxidant Nrf2 signaling by substituted trans stilbenes.
Lorraine M Deck, Lisa J Whalen, Lucy A Hunsaker, Robert E Royer, David L Vander Jagt

Bioorg Med Chem· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
Olivia Moran, Dina Nikitina, Robert Royer, Aletta Poll, Kelly Metcalfe

Breast Cancer Res Treat· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago.
Talia Donenberg, Humayun Ahmed, Robert Royer, Shiyu Zhang, Steven A Narod

Breast Cancer Res Treat· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling Fanconi Anemia Gene Mutations among Iranian Patients.
Giti Esmail Nia, Mahsa Fadaee, Robert Royer, Hossein Najmabadi, Mohammad R Akbari

Arch Iran Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer.
Gabriela Torres-Mejía, Robert Royer, Marcia Llacuachaqui, Mohammad R Akbari, Anna R Giuliano

Cancer Epidemiol Biomarkers Prev· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia.
Julián Esteban Londoño Hernández, Marcia Llacuachaqui, Gonzalo Vásquez Palacio, Juan David Figueroa, Jorge Madrid, Robert Royer

Hered Cancer Clin Pract· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early onset breast cancer in a registry-based sample of African-american women: BRCA mutation prevalence, and other personal and system-level clinical characteristics.
Tuya Pal, Devon Bonner, Jongphil Kim, Alvaro N A Monteiro, Lisa Kessler, Robert Royer

Breast J· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer.
Mohammad R Akbari, Wojciech Kluźniak, Rachelle Rodin, Song Li, Dominika Wokołorczyk, Robert Royer

Breast Cancer Res Treat· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A chemical analog of curcumin as an improved inhibitor of amyloid Abeta oligomerization.
Robert A Orlando, Amanda M Gonzales, Robert E Royer, Lorraine M Deck, David L Vander Jagt

PLoS One· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The R337H mutation in TP53 and breast cancer in Brazil.
Magda Cb Gomes, Joanne Kotsopoulos, Gutemberg Leão de Almeida, Mauricio M Costa, Roberto Vieira, Robert Royer

Hered Cancer Clin Pract· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia.
Alexandra Ortiz Rodríguez, Marcia Llacuachaqui, Gonzalo Guevara Pardo, Robert Royer, Garrett Larson

Gynecol Oncol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The BRCA2 c.9004G>A (E2002K) [corrected] variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent.
Stephanie Cote, Suzanna L Arcand, Robert Royer, Serge Nolet, Anne-Marie Mes-Masson

Breast Cancer Res Treat· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of benzyl substituted naphthalenes from benzylidene tetralones.
Lorraine M Deck, Quintino Mgani, Andrea Martinez, Alice Martinic, Lisa J Whalen, Robert E Royer

Tetrahedron Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes.
Mohammad R Akbari, Shiyu Zhang, Isabel Fan, Robert Royer, Song Li

J Med Genet· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Greece.
Chrissovaladis Koumpis, Constantine Dimitrakakis, Aris Antsaklis, Robert Royer, Shiyu Zhang

Hered Cancer Clin Pract· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation.
Ana Peixoto, Catarina Santos, Manuela Pinheiro, Pedro Pinto, Maria José Soares, Robert Royer

Breast Cancer Res Treat· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer.
Shiyu Zhang, Robert Royer, Song Li, John R McLaughlin, Barry Rosen

Gynecol Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas.
Talia Donenberg, John Lunn, Duvaughn Curling, Theodore Turnquest, Elisa Krill-Jackson, Robert Royer

Breast Cancer Res Treat· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of Hemigossypol and its Derivatives.
Jun Wei, David L Vander Jagt, Robert E Royer, Lorraine M Deck

Tetrahedron Lett· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube.
Danielle Vicus, Amy Finch, Ilana Cass, Barry Rosen, Joan Murphy, Robert Royer

Gynecol Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of nuclear factor kappaB activation and cyclooxygenase-2 expression by aqueous extracts of Hispanic medicinal herbs.
Robert A Orlando, Amanda M Gonzales, Lucy A Hunsaker, Carolina R Franco, Robert E Royer

J Med Food· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.
Anne Le, Charles R Cooper, Arvin M Gouw, Ramani Dinavahi, Anirban Maitra, Robert E Royer

Proc Natl Acad Sci U S A· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.
Kelly A Metcalfe, Aletta Poll, Robert Royer, Marcia Llacuachaqui, Anna Tulman

J Clin Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis